JUND and cancer: Collectively, we identified a total of 71 distinct LTR10 enhancers (table S14) predicted to contribute to the regulation of roughly 12% of genes with AP1- or MAPK-dependent gene expression in HCT116 cells, supporting an important role in mediating global transcriptional rewiring in cancer.